Rafferty Asset Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

A detailed history of Rafferty Asset Management, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 122,490 shares of CPRX stock, worth $2.65 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

122,490

Previous 185,494 33.97%

Holding current value

$2.65 Million

Previous $2.87 Million 15.25%

% of portfolio

0.01%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.19 - $21.35 $957,030 - $1.35 Million	-63,004 Reduced 33.97%	122,490 $2.44 Million
Q2 2024 Aug 13, 2024	SELL	$14.68 - $16.92 $4.42 Million - $5.1 Million	-301,280 Reduced 61.89%	185,494 $2.87 Million
Q1 2024 May 13, 2024	BUY	$13.18 - $17.11 $1.77 Million - $2.3 Million	134,612 Added 38.22%	486,774 $7.76 Million
Q4 2023 Feb 13, 2024	SELL	$11.78 - $17.29 $1.86 Million - $2.74 Million	-158,273 Reduced 31.01%	352,162 $5.92 Million
Q3 2023 Nov 13, 2023	SELL	$11.69 - $15.02 $2.39 Million - $3.07 Million	-204,440 Reduced 28.6%	510,435 $5.97 Million
Q2 2023 Aug 11, 2023	BUY	$11.5 - $18.08 $2.88 Million - $4.52 Million	250,208 Added 53.85%	714,875 $9.61 Million
Q1 2023 May 11, 2023	SELL	$14.34 - $21.05 $398,422 - $584,853	-27,784 Reduced 5.64%	464,667 $7.7 Million
Q4 2022 Feb 13, 2023	BUY	$12.25 - $19.5 $1.07 Million - $1.71 Million	87,742 Added 21.68%	492,451 $9.16 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $1.54 Million - $3.39 Million	218,609 Added 117.47%	404,709 $5.19 Million
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $282,891 - $389,146	-45,408 Reduced 19.61%	186,100 $1.31 Million
Q1 2022 May 13, 2022	BUY	$5.31 - $8.31 $15,505 - $24,265	2,920 Added 1.28%	231,508 $1.92 Million
Q4 2021 Feb 10, 2022	BUY	$5.21 - $7.45 $186,528 - $266,724	35,802 Added 18.57%	228,588 $1.55 Million
Q3 2021 Nov 10, 2021	BUY	$4.85 - $6.04 $2,880 - $3,587	594 Added 0.31%	192,786 $1.02 Million
Q2 2021 Aug 10, 2021	SELL	$4.29 - $6.05 $1.05 Million - $1.47 Million	-243,632 Reduced 55.9%	192,192 $1.11 Million
Q1 2021 May 10, 2021	BUY	$3.45 - $4.69 $1.29 Million - $1.76 Million	375,238 Added 619.35%	435,824 $2.01 Million
Q4 2020 Feb 10, 2021	SELL	$2.97 - $3.83 $513,049 - $661,609	-172,744 Reduced 74.03%	60,586 $202,000
Q3 2020 Nov 13, 2020	BUY	$2.97 - $5.08 $440,834 - $754,019	148,429 Added 174.83%	233,330 $693,000
Q2 2020 Aug 07, 2020	BUY	$3.48 - $5.05 $176,968 - $256,807	50,853 Added 149.36%	84,901 $392,000
Q1 2020 May 15, 2020	SELL	$2.61 - $5.21 $856,727 - $1.71 Million	-328,248 Reduced 90.6%	34,048 $131,000
Q4 2019 Feb 10, 2020	BUY	$3.67 - $5.7 $707,862 - $1.1 Million	192,878 Added 113.85%	362,296 $1.36 Million
Q3 2019 Nov 14, 2019	BUY	$3.89 - $7.43 $659,036 - $1.26 Million	169,418 New	169,418 $900,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.22B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account

Rafferty Asset Management, LLC Catalyst Pharmaceuticals, Inc. Transaction History